Who is Speaking at INVEST 2025?

The healthcare investor conference, scheduled for May 20 and 21 at the Willis Tower in Chicago, combines panel discussions, networking opportunities, and a startup pitch contest. Register today! The post Who is Speaking at INVEST 2025? appeared first on MedCity News.

Read More

Novartis’s $925M Anthos Acquisition Brings Back Cardio Drug That Stops Blood Clots

The Anthos Therapeutics acquisition represents a homecoming for its drug abelacimab, which originated in Novartis’s labs. The antibody offers the potential to prevent blood clots without the bleeding risks associated with currently available anticoagulants. The post Novartis’s $925M Anthos Acquisition Brings Back Cardio Drug That Stops Blood Clots appeared first on MedCity News.

Read More

Intermountain Health Exec: Hub-and-Spoke Models Could Save Rural Healthcare

Dan Liljenquist, Intermountain Health’s chief strategy officer, said that more large health systems should employ a hub-and-spoke model to ensure that rural providers can thrive. Under this model, large health systems partner with rural hospitals — with the rural “spoke” hospitals gaining access to the larger “hub” health system’s technology, staff, medication discounts and more….

Read More